MEDA Pharma GmbH & Co. KG

Research activity includes adults living with pancreatic exocrine insufficiency following total pancreatectomy, with attention to the ongoing need for pancreatic enzyme replacement therapy in post-surgical care.

• Post-pancreatectomy digestive support
• Pancreatic enzyme replacement therapy
• Exocrine pancreatic function

The therapeutic focus extends to managing malabsorption-related symptoms and supporting nutritional intake in patients with loss of pancreatic enzyme production.